Iluvien 0.19mg Intravitreal Implant (Fluocinolone Acetonide Others) 0.19mg

Iluvien 0.19mg intravitreal implant contains fluocinolone acetonide for sustained ocular delivery. This non-biodegradable implant is designed for long-term treatment of chronic eye conditions. Suitable for patients requiring localized corticosteroid therapy. Ideal for those seeking targeted retinal support.

Strength

0.19mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Alimera Sciences, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Iluvien 0.19mg intravitreal implant is used to treat chronic non-infectious uveitis affecting the posterior segment of the eye. It provides sustained release of fluocinolone acetonide to reduce inflammation in the retina. This implant is also indicated for diabetic macular edema in patients who have been previously treated with corticosteroids and did not have a significant rise in intraocular pressure. It helps maintain vision by controlling swelling and inflammation.

Side Effects

The implant gradually releases medication to help reduce swelling and inflammation in the eye. Patients may notice improved clarity and comfort over time as inflammation subsides. Some may experience temporary mild irritation or redness after the procedure. Vision may appear slightly blurred immediately following insertion.

Precautions & Warnings

This implant should only be administered by a qualified healthcare professional experienced in intravitreal procedures. Patients with active eye infections or glaucoma should discuss risks with their doctor. Regular follow-up visits are important to monitor eye pressure and overall response. Avoid rubbing or pressing on the treated eye after insertion.

Avoid Interactions

No direct drug interactions are expected since the medication acts locally within the eye. Systemic absorption is minimal, reducing the risk of interactions with oral or injectable medications. Patients using other eye drops should inform their doctor to ensure compatibility. Alcohol consumption does not typically affect the implant’s performance.

Frequently Asked Questions

The implant releases medication gradually over approximately 36 months. Its effects are designed to provide sustained treatment during this period.

The implant is intended for chronic conditions requiring prolonged therapy. Safety depends on individual patient factors and should be assessed by a healthcare provider.

Vision may be temporarily blurred after the procedure. Avoid driving until your doctor confirms it is safe to do so.

Avoid rubbing the eye, swimming, or using eye makeup for a period recommended by your doctor. Follow all post-procedure care instructions.

Patients with active eye infections, uncontrolled glaucoma, or known hypersensitivity to fluocinolone acetonide should avoid this treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.